TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-KAPPA-B ACTIVITY INHIBITORS - Patent 1169049

(19)

(11)

EP 1 169 049 A2

(12)

(88)	Date of publication A3:
	11.01.2001

(43)	Date of publication:
	09.01.2002 Bulletin 2002/02

(21)	Application number: 00921764.7

(22)	Date of filing: 07.04.2000

(51)	International Patent Classification (IPC)⁷: A61K 38/04, A61K 31/40, A61K 31/166, A61P 19/08

(86)	International application number:
	PCT/US0009/121

(87)	International publication number:
	WO 0061/167 (19.10.2000 Gazette 2000/42)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

09.04.1999 US 289229

(71)	Applicant: Osteoscreen, Inc.
	San Antonio, TX 78229 (US)

(72)	Inventor:
	Mundy, Gregory R. San Antonio, TX 78229 (US)

(74)	Representative: Sexton, Jane Helen et al
	J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5JJ London WC1R 5JJ (GB)

(54)	TREATMENT OF MYELOMA BONE DISEASE WITH PROTEASOMAL AND NF-KAPPA-B ACTIVITY INHIBITORS